Avicanna Inc

AVCN

Company Profile

  • Business description

    Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. It has three operating segments: Canada, International, and Corporate. It generates the majority of its revenue from Canada.

  • Contact

    480 University Avenue
    Suite 1502
    TorontoBCM5G 1V2
    CAN

    T: +1 647 243-5283

    https://www.avicanna.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    87

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,826.4015.50-0.18%
CAC 407,723.4727.200.35%
DAX 4024,073.67286.221.20%
Dow JONES (US)44,406.36422.17-0.94%
FTSE 1008,806.5316.38-0.19%
HKSE23,887.8328.23-0.12%
NASDAQ20,412.52188.59-0.92%
Nikkei 22539,587.68223.20-0.56%
NZX 50 Index12,755.749.21-0.07%
S&P 5006,229.9849.37-0.79%
S&P/ASX 2008,589.3013.70-0.16%
SSE Composite Index3,473.130.810.02%

Market Movers